Michelle McMurry-Heath,
MD, PhD
Audit Committee Member
Vice President, Worldwide Regulatory Affairs
Johnson & Johnson
Dr. McMurry-Heath is a physician and scientist with more than two decades of experience bridging the gap between science and policy and between medical solutions and patients. She has committed her life's work to providing patients with better health information and greater clinical options. Her bench training in molecular immunology only enhanced her resolve to facilitate the diffusion of innovative science into the practice of medicine.
Dr. McMurry-Heath oversaw health for Senator Joseph Lieberman and was the senior health policy advisor for the Lieberman for President Campaign. She was the founding director of the Aspen Institute's Health, Biomedical Science and Society Initiative, which brought pharmaceutical leaders together with leaders in patient advocacy and health care to focus on projects on issues ranging from regulation to tackling chronic diseases in the context of health insurance reform. Her health diplomacy work included projects in eleven countries, including Cambodia and Rwanda.
From 2010 – 2014, Dr. McMurry-Heath was the Associate Center Director for Science at the US Food and Drug Administration's Center for Devices and Radiological Health. She led the US Food and Drug Administration team tasked with defining a new role for patients in the regulation of medical devices and diagnostics. She drew on this experience as the primary architect of the Medical Device Innovation Consortium, a novel public-private partnership between the US Food and Drug Administration and almost 50 members of the medical technology industry and patient advocacy community. Medical Device Innovation Consortium members have pooled resources and talent to take on some of the most intractable topics in medical device innovation: optimizing clinical trials, applying computer modeling to device design and regulation, compliance science, pathways for insuring the clinical validity of new diagnostics, and the science behind measuring patient preferences. She joined Johnson & Johnson as Worldwide Vice President of Regulatory Affairs for medical devices. Dr. McMurry-Heath studied biochemistry at Harvard University, and went on to become the first African-American to receive both MD and PhD degrees from Duke University.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China